Latest Ratings for BYRN Date Firm Action From To Feb 2022 Ladenburg Thalmann Maintains Buy Feb 2022 B. Riley Securities Maintains Buy Feb 2022 Raymond James Maintains Strong Buy View More Analyst Ratings for BYRN View the Latest A...
Read Also
- NEA approves credit facility to support power co-ops’ non-network, grid projects
- Easier to tax, easier to pay, easier to collect
- Carnival Cruise Line passengers banned after a really dumb move
- No amendment to pilot duty time rules, DGCA denies airline claims
- IT Department seeks suggestions for comprehensive review of Income-Tax Act
- Royal Caribbean shares an urgent Hurricane Milton warning
- 6 Analysts Have This To Say About Applied Industrial Techs
- What's Going On With US Listed Chinese Stocks Alibaba, JD, Nio, Li Auto XPeng on Monday?
- What's Going On With US Listed Chinese Stocks Alibaba, JD, Nio, Li Auto XPeng on Monday?
- No Wi-Fi? No Worries with Microsoft Office 2021 — Just $39.97 Right Now.
Latest Benzinga
- 6 Analysts Have This To Say About Applied Industrial Techs
- What's Going On With US Listed Chinese Stocks Alibaba, JD, Nio, Li Auto XPeng on Monday?
- What's Going On With US Listed Chinese Stocks Alibaba, JD, Nio, Li Auto XPeng on Monday?
- CrowdStrike, Deckers, Ares Management And A Big Bank Stock On CNBC's 'Final Trades'
- CrowdStrike, Deckers, Ares Management And A Big Bank Stock On CNBC's 'Final Trades'
- FDA Put Brakes On Penny Stock Kezar Life Sciences' Mid-Stage Study For Lead Development Candidate After Patient Deaths
- Algorhythm's SemiCab Scores Work With $200B Client, Unlocking Expansion Potential
- FDA Put Brakes On Penny Stock Kezar Life Sciences' Mid-Stage Study For Lead Development Candidate After Patient Deaths
- Algorhythm's SemiCab Scores Work With $200B Client, Unlocking Expansion Potential
- Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?